Author:
Atkinson Rachel L.,El-Zein Randa,Valero Vicente,Lucci Anthony,Bevers Therese B.,Fouad Tamer,Liao Weiqin,Ueno Naoto T.,Woodward Wendy A.,Brewster Abenaa M.
Funder
National Institutes of Health
Cancer Center Support Grant
The State of Texas Grant for Rare and Aggressive Breast Cancer
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the national cancer institute. J Natl Cancer Inst 97:966–975
2. Low JA, Berman AW, Steinberg SM, Danforth DN, Lippman ME, Swain SM (2004) Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy. J Clin Oncol 22:4067–4074
3. Natori A, Hayashi N, Soejima K, Deshpande GA, Takahashi O, Cristofanilli M et al (2013) A comparison of epidemiology, biology, and prognosis of inflammatory breast cancer in Japanese and US populations. Clin Breast Cancer 13:460–464
4. Tsai CJ, Li J, Gonzalez-Angulo AM, Allen PK, Woodward WA, Ueno NT et al (2013) Outcomes after multidisciplinary treatment of inflammatory breast cancer in the era of neoadjuvant HER2-directed therapy. Am J Clin Oncol
5. Sorlie T, Perou R, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869–10874
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献